Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Basal-like 1 triple-negative breast cancer (BL1), KEYNOTE-522, Pathologic complete response (pCR), PI3K / AKT / mTOR and the tags breast, tnbc, subtype-page.
Shares KEYNOTE-522, PI3K / AKT / mTOR, Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares KEYNOTE-522, Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares Basal-like 1 triple-negative breast cancer (BL1), Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares PI3K / AKT / mTOR, Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares KEYNOTE-522, Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
Shares Basal-like 1 triple-negative breast cancer (BL1), Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
Shares Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
The same record for scripts and assistants; checked 2026-09-24. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.